Il-18 binding protein (il-18bp) in inflammatory diseases
AssigneeAB2 Bio SA
InventorsAndrea PFEIFER, Greg DEL VAL
Life of this patent
Estimating the term…
Abstract
The present invention provides means and methods for treating Interleukin 18 (IL-18)-associated diseases and disorders. In particular, the present invention discloses antibodies specific for free IL-18 and IL-18 Binding Protein (IL-18BP) for use in such treatments and for the diagnosis of the indications.
Claims21
A method for treating an IL-18 associated disease or disorder in a population of subjects diagnosed of having abnormal levels of free IL-18 and/or an abnormal ratio of free IL-18/IL-18 binding protein (IL-18BP) in the body fluids compared to the levels in the body fluids of a healthy control subject, or of having a predisposition to develop such a disease or disorder, comprising administering to said subject a therapeutically or prophylactically effective amount of an IL-18 inhibitor.
A method for treating an IL-18 associated disease or disorder in a population of subjects diagnosed of having abnormal levels of free IL-18 and/or an abnormal ratio of free IL-18/IL-18 binding protein (IL-18BP) in the body fluids compared to the levels in the body fluids of a healthy control subject, or of having a predisposition to develop such a disease or disorder, comprising administering to said subject a therapeutically or prophylactically effective amount of an IL-18 inhibitor, wherein the level of free IL-18 in the body fluids of the subjects has been determined by an immunoassay.
Dependencies are inferred from the claim text.